Chase Shen

Additional constraints during biomarker method development: case studies

Gilda Shayan, S. Purushothama, S. Gopal, 2016 .

CellsT Cell Impairment in the Absence of CD4 T mTORC1 Activation Underlie Memory CD8 - Persistent Antigen and Prolonged AKT

B. Zhu, H. Eisen, Chase Shen, 2015 .

A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosus

L. Lesko, I. Nestorov, L. Stevenson, 2020, Journal of Pharmacokinetics and Pharmacodynamics.

PAN-TAU ANTIBODY BIIB076 EXHIBITS PROMISING SAFETY AND BIOMARKER PROFILE IN CYNOMOLGUS MONKEY TOXICITY STUDY

G. Cantone, C. Wager, C. Stebbins, 2017, Alzheimer's & Dementia.

Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum.

Shobha Purushothama, Alvydas Mikulskis, Alvydas Mikulskis, 2016, Journal of immunological methods.

Promiscuous binding of extracellular peptides to cell surface class I MHC protein

R. J. Cohen, Kaidi Wang, Jianzhu Chen, 2012, Proceedings of the National Academy of Sciences.

Persistent Antigen and Prolonged AKT–mTORC1 Activation Underlie Memory CD8 T Cell Impairment in the Absence of CD4 T Cells

Jianzhu Chen, H. Eisen, Yingzhong Li, 2015, The Journal of Immunology.

A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosus

L. Lesko, I. Nestorov, L. Stevenson, 2020, Journal of Pharmacokinetics and Pharmacodynamics.